|Year : 2017 | Volume
| Issue : 3 | Page : 315-317
Recovery of Mycobacterium lentiflavum from bronchial lavage during follow-up of an extrapulmonary tuberculosis patient
Esther Vise1, Michael Mawlong2, Akshay Garg3, Arnab Sen4, Ingudam Shakuntala4, Samir Das4
1 Division of Animal Health, Indian Council of Agricultural Research (ICAR), Research Complex for North Eastern Hill Region, Umiam, Meghalaya; School of Bio-Engineering and Bio-Sciences, Lovely Professional University, Phagwara, Punjab, India
2 Department of Microbiology and Mycobacteriology, Nazareth Hospital, Shillong, Meghalaya, India
3 School of Bio-Engineering and Bio-Sciences, Lovely Professional University, Phagwara, Punjab, India
4 Division of Animal Health, Indian Council of Agricultural Research (ICAR), Research Complex for North Eastern Hill Region, Umiam, Meghalaya, India
|Date of Web Publication||31-Jul-2017|
Division of Animal Health, Indian Council of Agricultural Research (ICAR), Research Complex for North-Eastern Hill Region, Umiam - 793 103, Meghalaya
Source of Support: None, Conflict of Interest: None
Initially diagnosed with cervical lymphadenitis, a 15-year-old boy was started with category I anti-tuberculosis (TB) drugs. Follow-up investigations led to isolation and identification of Mycobacterium lentiflavum by multiple diagnostic and identification approaches. Observation of this rare pathogen from human origin urges cautious diagnosis while attending TB cases.
Keywords: Extrapulmonary tuberculosis, India, lymphadenitis, Mycobacterium lentiflavum, tuberculosis
|How to cite this article:|
Vise E, Mawlong M, Garg A, Sen A, Shakuntala I, Das S. Recovery of Mycobacterium lentiflavum from bronchial lavage during follow-up of an extrapulmonary tuberculosis patient. Int J Mycobacteriol 2017;6:315-7
|How to cite this URL:|
Vise E, Mawlong M, Garg A, Sen A, Shakuntala I, Das S. Recovery of Mycobacterium lentiflavum from bronchial lavage during follow-up of an extrapulmonary tuberculosis patient. Int J Mycobacteriol [serial online] 2017 [cited 2021 Oct 28];6:315-7. Available from: https://www.ijmyco.org/text.asp?2017/6/3/315/211925
| Introduction|| |
Mycobacterium lentiflavum, a slow-growing, pigmented nontuberculous Mycobacterium, is a rare entity of human disease. Thomas et al., on analyzing 48 cases of M. lentiflavum infection observed lung as a common site of infection in adults and cervical lymphadenitis to be a common manifestation in minors. Similar manifestations in pediatric cases by M. lentiflavum with poor treatment outcome were also reported., Nontuberculous mycobacterial infections are of therapeutic challenge as clinical presentation is often indistinguishable from tuberculosis (TB), and species-specific treatment scheme is necessary. Reviewing the currently recommended guidelines on the aspects of mycobacterial treatment, Esteban et al. also highlighted the difficulty to establish proper guidelines for rare pathogenic species. Although Mycobacterium fortuitum, Mycobacterium avium complex, Mycobacterium abscessus, and Mycobacterium chelonae remain the common clinical isolations of nontuberculous mycobacteria (NTM) in Asia and Middle-East countries,, the distribution of NTM is diverse even within a country. With rampant increase in NTM isolations, careful discernment of clinical significance and colonization or contamination is important as environment plays a key role in harboring these entities. Water-related nosocomial outbreak by M. abscessus in a pediatric surgical ward has been reported from India. In this study, we report the isolation of M. lentiflavum from bronchial lavage of a boy associated with cervical lymphadenitis and lung consolidation.
| Case Report|| |
A 15-year-old boy reported to a government block-level dispensary with scrotal inflammation and pain. The clinical symptoms included weight loss, lymphadenitis, intermittent fever, ascites, and hydrocele. He was clinically suspected to be suffering from extrapulmonary TB-cervical Koch's lymphadenitis. Further tests showed positive Mantoux test, acid-fast bacilli in cervical lymph node biopsy, and a negative sputum smear. Erythrocyte sedimentation rate (ESR) was mildly raised (20 mm/h), lung X-ray presented prominent mediastinal lymph nodes, and lower abdominal ultrasound revealed moderate ascites with few subcentimeter mesenteric lymph node in the preumblical region. The patient was started on category I anti-TB drugs, and the HIV status is unknown. Though advised an operative procedure for hydrocele, the procedure could not be performed for economic reasons. Given the mother's health history of succumbing to TB, the patient was closely examined for TB while reporting for scrotal pain and inflammation.
The follow-up laboratory test results at the end of 6-month treatment course are as follows: ESR elevated (34 mm/h), alkaline phosphatase on the upper limit (202 U/L), and left pleural effusion with the underlying consolidation in lung X-ray. The ascites and cervical lymph node swelling had subsided. The case was then referred to a tertiary care hospital acquiring a Revised National Tuberculosis Control Program unit with better-equipped identification facility for Mycobacterium species for further investigation. The child's bronchial lavage was acid-fast smear negative but was flagged as positive for Mycobacterium species when inoculated in BACTEC MGIT ™ 320 (Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA), with culture showing acid-fast report of 3+ grade. The isolate (PK504) was presumed as NTM on the basis of a negative MPT64 protein detection-based immunochromatographic test (SD MPT64TB Ag Kit, Standard Diagnostics, Inc., Gyeonggi-do, South Korea). This led to change of treatment to NTM treatment regimen comprising rifampicin (300 mg/day), isoniazide (300 mg/day), ethambutol (600 mg/day), and clarithromycin (500 mg/day). In between these two mycobacterial treatments, he had been prescribed two short courses of conventional antibiotics.
The isolate was shared with our laboratory and species was confirmed to be M. lentiflavum with the help of culture growth [Figure 1] and molecular tests. An informed consent was obtained from the patient after clear understanding of the study purpose. Biochemical tests such was niacin production, nitrate reductase, catalase, and pyrazinamidase were also performed. The isolate was positive for catalase (heat stable and semiquantitative) and pyrazinamidase but negative for niacin production and nitrate reductase. For molecular identification, DNA was extracted by DNA isolation kit (Qiagen Inc., Valencia, USA) and used in polymerase chain reaction (PCR) amplification for Mycobacterium genus-specific hsp65 gene which amplified a partial 441 bp segment, confirming it to be of Mycobacterium genus. The species-specific PCR for Mycobacterium tuberculosis and Mycobacterium bovis was also tested with RD9, RD4, and 500 bp primers which were all negative for M. tuberculosis complex, suggesting the isolate to be NTM. PCR-restriction enzyme pattern analysis (PRA) was performed on the purified product of hsp 65 amplicon using the enzymes Bst EII and Hae III (New England Biolabs Inc., USA) to identify the species. The band fragmentation pattern (Bst EII-no digestion; Hae III-145/130 bp) directed the isolate to three NTM species, namely, M. lentiflavum, Mycobacterium florentinum, and Mycobacterium simiae, as per the published algorithm of PRA-hsp65 patterns. In addition, the purified PCR product of hsp65 was also sequenced and submitted to GenBank, National Center for Biotechnology Information (NCBI) (KX431212). The isolate's hsp65 sequence was used for blast analysis in the NCBI for identification which depicted 100% match to M. lentiflavum. Phylogenetic analysis was also carried out based on the sequenced hsp65 gene of the isolate along with the reference strain of M. lentiflavum (AF547851), other closely related species (GQ153292, JF491317), the best matches of BLAST results (KF432468, KF432466, KF432457), and two out-groups (AY299144, AF547813). All sequences were aligned using ClustalW program in the freely available online software tool MEGA6 (www.megasoftware.net/), and the dendrogram was inferred using the maximum likelihood approach [Figure 2]. The phylogenetic tree depicted the isolate (PK504) to be M. lentiflavum, forming a clad with reference and clinical Chinese strains of M. lentiflavum. Following gene sequence identification, the isolate was also identified with MALDI-TOF technology given its significance as a clinical diagnostic tool. Using freshly grown culture, the isolate was processed according to the manufacturer's protocol with Escherichia coli ATCC 8739 as control. Employing the SARAMIS Research Use Only database in MALDI-TOF Vitek MS system (BioMerieux, France), the isolate was identified as M. lentiflavum with a percent probability value of 86.9%. After species confirmation, the same NTM therapeutic regimen was continued as the boy responded positively to the therapy. The patient is cured of lymphadenitis, lung consolidation, and ascites. Regaining vigor, he is able to pursue academics and perform daily activities.
|Figure 1: Smooth, scotochromogenic colonies observed on Lowenstein–Jensen medium (glycerol)|
Click here to view
|Figure 2: Dendrogram inferred using maximum likelihood method showing isolate PK504 forming distinct clade with reference sequences of Mycobacterium lentiflavum. Mycobacterium tuberculosis and Mycobacterium tuberculosis and Mycobacterium bovis used as out groups. The percentage of trees in which the associated taxa are clustered together is shown next to the branches|
Click here to view
| Discussion|| |
The study accounts the isolation of M. lentiflavum from a minor suffering from Koch's lymphadenitis or scrofula who had already completed 6-month course of category I anti-TB drug regimen. The relapse cases of TB are either drug-resistant TB or NTM infections. Such cases in resource-constrained settings are very often misdiagnosed or sometimes given appropriate attention only after obtaining a history of failed anti-TB treatments. Rapid, affordable, and differential diagnostics adjunct to collaborative efforts will effectively mitigate such episodes. M. lentiflavum isolated in this study depicts the presence of this rarely reported pathogen in the country which cannot be overlooked as it may represent many such unreported cases. The number of NTM cases has not only been increasing in the region but rare NTM species are also being reported which makes clinical diagnosis and treatment challenging, especially in lesser developed settings.
This case of M. lentiflavum isolated from a child with lymphadenitis is possibly only the second report of M. lentiflavum isolation from human source and typical of its kind from child TB cases in India. The first isolation in the country was communicated from All India Institute of Medical Sciences, New Delhi, with a GenBank sequence submission of M. lentiflavum 16S rRNA gene (JQ037846). Isolation of this NTM species illustrates the clinical relevance of NTM infections in susceptible individuals and calls for cautious diagnosis and treatment while managing TB cases in this TB-laden country.
The authors thank the technical team of Mycobacteriology Laboratory, Department of Microbiology, Nazareth Hospital, for their technical assistance during this research work and the University Grants Commission-statutory body of the Government of India for awarding fellowship to carry out the Ph.D. research.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Thomas G, Hraiech S, Dizier S, Weiller PJ, Ene N, Serratrice J, et al.
Disseminated Mycobacterium lentiflavum
responsible for hemophagocytic lymphohistocytosis in a man with a history of heart transplantation. J Clin Microbiol 2014;52:3121-3.
Blyth CC, Best EJ, Jones CA, Nourse C, Goldwater PN, Daley AJ, et al.
Nontuberculous mycobacterial infection in children: A prospective national study. Pediatr Infect Dis J 2009;28:801-5.
Jiménez-Montero B, Baquero-Artigao F, Saavedra-Lozano J, Tagarro-García A, Blázquez-Gamero D, Cilleruelo-Ortega MJ, et al.
Comparison of Mycobacterium lentiflavum
and Mycobacterium avium-intracellulare
complex lymphadenitis. Pediatr Infect Dis J 2014;33:28-34.
Esteban J, García-Pedrazuela M, Muñoz-Egea MC, Alcaide F. Current treatment of nontuberculous mycobacteriosis: An update. Expert Opin Pharmacother 2012;13:967-86.
Lai CC, Hsueh PR. Diseases caused by nontuberculous mycobacteria in Asia. Future Microbiol 2014;9:93-106.
Velayati AA, Rahideh S, Nezhad ZD, Farnia P, Mirsaeidi M. Nontuberculous mycobacteria in Middle East: Current situation and future challenges. Int J Mycobacteriol 2015;4:7-17. [Full text]
Halstrom S, Price P, Thomson R. Review: Environmental mycobacteria as a cause of human infection. Int J Mycobacteriol 2015;4:81-91. [Full text]
Raman LA, Siddiqi N, Shamim M, Deb M, Mehta G, Hasnain SE. Molecular characterization of Mycobacterium abscessus
strains isolated from a hospital outbreak. Emerg Infect Dis 2000;6:561-2.
Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993;31:175-8.
Chimara E, Ferrazoli L, Ueky SY, Martins MC, Durham AM, Arbeit RD, et al.
Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65 patterns. BMC Microbiol 2008;8:48.
Shamaei M, Marjani M, Farnia P, Tabarsi P, Mansouri D. Human infections due to Mycobacterium lentiflavum
:First report in Iran. Iran J Microbiol 2010;2:27-9.
[Figure 1], [Figure 2]
|This article has been cited by|
||Molecular Speciation of Mycobacterial Isolates from Raw Cow Milk Reveals Predominance of Mycobacterium chelonae
| ||Esther Vise,Akshay Garg,Sandeep Ghatak,Amarjit Karam,Uttaran Bhattacharjee,Arnab Sen,Ingudam Shakuntala,Kekungu Puro,Rajkumari Sanjukta,Neeta Raj Sharma,Samir Das |
| ||Proceedings of the National Academy of Sciences, India Section B: Biological Sciences. 2017; |
|[Pubmed] | [DOI]|